- The trend backdrop is active with a 14-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
NIVABUPA
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Niva Bupa Health Insurance Company Limited · Financial Services · Insurance - Life
Latest close
86.19 INR
-0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 8.0% above the Trend Line and sits at 78.4% of its 52-week range. The latest completed week returned -0.4%, after a -0.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 62/100. Near-term considerations: volume confirmation is below normal.
Setup score
58
out of 100
Latest Close
86.19 INR
7 Aug 2026
1W Return
-0.4%
latest completed week
4W Return
-0.4%
short-term follow-through
12W Return
8.0%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.4%
Latest completed week; four-week move -0.4%.
Indicator stack
66/64
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
62/100
38 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 8.0% above the Trend Line and sits at 78.4% of its 52-week range. The latest completed week returned -0.4%, after a -0.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7912-week average 0.58
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.79Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.4% over four weeks, 8.0% over 12 weeks, and 7.8% over one year. The current trend has remained active for 14 consecutive weeks.
Performance by holding period
Active trend streak14 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.89Latest activity-pressure read.
Pressure change-21.8%Four-week change in activity pressure.
Leadership9.55Latest relative-leadership reading.
RS change-20.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 73%
Model confidence 68%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength16/100Blend of value, momentum, and quality. Underlying universe rank 85; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality27/100Profitability and accounting quality. Underlying universe rank 74; rank 1 is best.
Momentum72/100Medium-term price momentum. Underlying universe rank 29; rank 1 is best.
Growth34/100Revenue and earnings growth. Underlying universe rank 67; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 121.9x Price divided by trailing earnings.
- Price / sales
- 2.2x Market value relative to trailing revenue.
- EV / EBITDA
- 73.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 5.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 2.6% Operating profit retained from revenue.
- Free-cash-flow margin
- 12.1% Free cash flow generated from revenue.
- Return on invested capital
- 4.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 24.9% Latest one-year revenue growth.
- EPS growth
- -39.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -46.9% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.1% Net share repurchases relative to market value.
- Shareholder yield
- -0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment62/100
Weighted news tone is positive across 38 relevant articles.
19 positive · 19 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.6%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+8.7%Week of 17 Apr.
Worst week-4.6%Week of 6 Mar.
Latest week-0.4%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains10
Flat weeks0
Modest losses13
Sharp losses1
Recent vol2.7%13-week weekly-return volatility.
Base vol2.9%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew2.6% / -1.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Financial Services
4-week rank47 / 100
Group average-0.9%
Trend breadth59.0%
Trend59.0%active weekly trend signals
MD70.0%positive activity pressure
RS57.0%positive relative leadership
Four-week leaders
IndustryIN Insurance - Life
4-week rank2 / 9
Group average-4.5%
Trend breadth44.4%
Trend44.4%active weekly trend signals
MD77.8%positive activity pressure
RS22.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis88/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.79; No reversal markers Factors30/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 79; Small Cap Core rank 88 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment62/100Weighted news tone is positive across 38 relevant articles.
Niva Bupa Health Insurance profit surges 93% in Q1FY27 on margin gains Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 86.19 INR | -0.4% | 79.78 INR | 79.83 INR | 0.89 | 9.55 | 4.6M | On |
| 31 Jul 2026 | 86.54 INR | -0.1% | 79.54 INR | 79.76 INR | 1.06 | 10.99 | 20.7M | On |
| 24 Jul 2026 | 86.64 INR | 0.7% | 79.16 INR | 79.68 INR | 1.08 | 14.16 | 3.6M | On |
| 17 Jul 2026 | 86.06 INR | -0.5% | 78.79 INR | 79.60 INR | 1.15 | 10.93 | 19.0M | On |
| 10 Jul 2026 | 86.51 INR | -0.1% | 78.43 INR | 79.53 INR | 1.14 | 12.07 | 5.7M | On |
| 3 Jul 2026 | 86.62 INR | 2.2% | 78.06 INR | 79.45 INR | 1.11 | 11.95 | 632.9K | On |
| 26 Jun 2026 | 84.79 INR | -2.4% | 77.63 INR | 79.36 INR | 1.07 | 10.72 | 0 | On |
| 19 Jun 2026 | 86.87 INR | 3.5% | 77.28 INR | 79.30 INR | 1.09 | 13.86 | 7.3M | On |
| 12 Jun 2026 | 83.96 INR | 1.9% | 76.90 INR | 79.20 INR | 1.09 | 12.13 | 788.4K | On |
| 5 Jun 2026 | 82.42 INR | -1.3% | 76.65 INR | 79.15 INR | 1.10 | 11.46 | 859.6K | On |
| 29 May 2026 | 83.50 INR | -2.9% | 76.44 INR | 79.11 INR | 1.11 | 12.19 | 4.4M | On |
| 22 May 2026 | 85.99 INR | 7.7% | 76.16 INR | 79.05 INR | 0.98 | 14.57 | 13.6M | On |
| 15 May 2026 | 79.83 INR | -1.8% | 75.77 INR | 78.96 INR | 0.73 | 6.73 | 69.4M | On |
| 8 May 2026 | 81.29 INR | 3.8% | 75.64 INR | 78.95 INR | 0.56 | 6.13 | 7.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.